Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE
Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE
Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
172 Special Solidarity Fund <strong>KCE</strong> Reports 133<br />
• The patient organisations don’t systematically provi<strong>de</strong> information<br />
towards the sickness funds. Ad hoc contacts are always linked to specific<br />
SSF cases where further clarification is nee<strong>de</strong>d. Patient organisations only<br />
intervene when they receive a specific request from a member.<br />
• Some organisations indicate that they maintain(ed) extensive contacts<br />
with politicians to get attention for the specific situation of the members<br />
they represent. These actions resulted in numerous parliamentary<br />
questions. They also gave the opportunity to have some specific individual<br />
patient situations put in the spotlight. These also raised media attention<br />
and created and more public awareness for rare diseases. Structural<br />
contacts directly related to the SSF with the ministry of health are<br />
seldom.<br />
9.12 RESULTS FROM THE INTERVIEWS WITH THE<br />
PRESCRIBING PHYSICIANS<br />
9.12.1 Knowledge on the existence of the SSF<br />
Most doctors learned of the existence of the SSF from their practice. None of the<br />
interviewees got preliminary information directly from the SSF itself. The following<br />
channels were mentioned: from the hospital’s social service, the sickness funds or its<br />
medical advisor, from colleagues, via a pharmaceutical company. Finally one interviewee<br />
could not recall how he first heard about the existence of the SSF.<br />
9.12.2 General information on SSF cases<br />
The number of cases submitted to the SSF is variable. Five of the respon<strong>de</strong>nts have a<br />
very limited number of SSF cases (1 to 2 on an annual basis) at the moment. Most of<br />
them had more cases in the past. The diminishment of the number of cases originates<br />
from drugs or medical <strong>de</strong>vices that were transferred to the regular health insurance<br />
system or drugs that have been accepted as orphan drugs. Five other respon<strong>de</strong>nts have<br />
between 5 and 10 SSF files a year, 2 have between 10 and 15 cases and one has about<br />
20 SSF files a year.<br />
Most of the medical doctors keep no separate track of SSF files and have no<br />
consolidated data on SSF applications. For some medical doctors interviewed, the social<br />
worker or the social nurse takes charge of the administrative process of preparing a SSF<br />
application file. These social workers or social nurses are part of a centralized social<br />
service at hospital following some doctors, this role is taken over by his secretary,<br />
others get the support from the hospitals administration or handle the files completely<br />
on their own. Overall the doctors have little contact with their colleagues from other<br />
disciplines in the hospital on sharing experience with SSF procedures. Most physicians<br />
confer occasionally with colleagues from other hospitals on SSF experiences.<br />
9.12.3 Need for a safety net/rele<strong>van</strong>ce of the SSF/effectiveness of the SSF<br />
On the question why the SSF has been established as a safety net next to the regular<br />
health insurance system, the respon<strong>de</strong>nts gave three major reasons which they also see<br />
as three major objectives for the SSF:<br />
• To allow new medical treatments not covered by the regular health<br />
insurance system and to reimburse the costs of these. As such the<br />
reimbursement by the SSF is a way to have solidarity at society level for<br />
exceptional individual medical cost of patients that have serious diseases.<br />
The SSF is perceived merely as a technique to limit the costs of new<br />
innovative medical treatments or drugs.<br />
• A way to facilitate the use of new medical treatments, medical <strong>de</strong>vices and<br />
drugs for patient care before all procedures to integrate them in the<br />
regular health insurance are completed.<br />
• A kind of waiting room for new techniques and drugs that allows public<br />
health authorities to get more un<strong>de</strong>rstanding on rele<strong>van</strong>ce and<br />
effectiveness.